Cronos Group (CRON) risk factors, FY2024 10-K

Risks Relating to Our Growth Strategy

1. 01We have a limited operating history and therefore we are subject to many of the risks common to early-stage enterprises
2. 02We may not be able to achieve or maintain profitability and may continue to incur losses in the future
3. 03We may not be able to successfully manage our growth
4. 04Our use of joint ventures may expose us to risks associated with jointly owned investments
5. 05There can be no assurance of continued growth in Israel and our performance in Israel depends on, among other things, our ability to continue to import cannabis into Israel and our joint venture partners
6. 06Our acquisition strategy may not be successful, and we have in the past, and may in the future, need to write down the goodwill and indefinite-lived intangible assets recognized upon the acquisitions
7. 07We are subject to disabilities as a result of our settlement with the SEC that may expose us to increased future litigation and adversely affect our ability to raise capital
8. 08There can be no assurance that our current and future strategic alliances or expansions of scope of existing relationships will have a beneficial impact on our business, financial condition and results of operations
9. 09Wholesale price volatility could have a material adverse effect on our business
10. 10We are anticipating further shortages in raw materials and may be unable to obtain adequate supplies of raw materials in a timely manner and at commercially reasonable prices
11. 11Our option to purchase a significant portion of Cronos GrowCo’s production could strain Cronos GrowCo’s ability to develop, maintain and grow profitable relationships with third party customers
12. 12Termination or non-renewal of the Cronos GrowCo Supply Agreement could have a material negative impact on our ability to obtain cannabis biomass at commercially viable prices
13. 13We may not successfully execute our production capacity strategy
14. 14Moreover, as a result of changes in the nature of our operations at the Peace Naturals Campus, the continued operations of the Cronos GrowCo Facility has become more important to us. The Cronos GrowCo Facility is our principal source of raw materials
15. 15We may not be able to successfully procure rare cannabinoids at commercially viable prices or in the quantities that we require
16. 16The industries and markets in which we operate are relatively new, and these industries and markets may not continue to exist or grow as anticipated or we may ultimately be unable to succeed in these industries and markets
17. 17We may not be able to supply the purchasers in various provinces and territories of Canada with our products in the quantities or prices anticipated, or at all
18. 18The adult-use cannabis market in Canada has in the past been and may in the future become oversupplied
19. 19We may be unsuccessful in competing in the legal adult-use cannabis market in Canada
20. 20We are subject to liability arising from any fraudulent or illegal activity by our employees, contractors, manufacturers and consultants
21. 21Some jurisdictions may never develop markets for cannabis
22. 22Our U.S. strategy in part depends on the success of the PharmaCann Investment and there is no guarantee that we will exercise the PharmaCann Option in the near term, or at all, and, even if exercised, that the PharmaCann Investment will achieve the expected benefits of the transaction
23. 23with obtaining approvals from or otherwise satisfying the requests of the state regulators or applicable laws, we may be required to divest all or a portion of the PharmaCann Option, or if after the exercise of the PharmaCann Option, our shares of PharmaCann
24. 24We rely largely on our own market research to forecast sales and market demand and market prices may differ from our forecasts
25. 25We could have difficulty integrating the operations of businesses that we have acquired and will acquire
26. 26We have been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which could have a material adverse effect on our results of operations or financial position
27. 27intangible assets exceed their fair value, the goodwill and other intangible assets are considered impaired, which would result in impairment losses and could have a material adverse effect on our consolidated financial position or results of operations

Risks Relating to Operations in Israel

1. 28We have operations in Israel through a strategic joint venture, Cronos Israel
2. 29Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Any losses or damage incurred by us could have an adverse effect on our business, financial condition, and results of operations
3. 30Our operations may be disrupted by the obligations of personnel to perform military service
4. 31The imposition of an anti-dumping duty on our imports into Israel could have a material adverse effect on our business, financial condition and results of operations

Risks Relating to Our Products

1. 32Clinical trials of cannabis-based medical products and treatments have a limited history, and any trials may not result in commercially viable products and treatments
2. 33The controversy surrounding vaporizers and vaporizer products may materially and adversely affect the market for vaporizer products and expose us to litigation and additional regulation
3. 34Future research may lead to findings that vaporizers, electronic cigarettes and related products are not safe for their intended use
4. 35We, or the cannabis industry more generally, may receive unfavorable publicity or become subject to negative consumer perception
5. 36We may be subject to litigation in the ordinary course of our marketing, distribution and sale of our products
6. 37We may be subject to product liability claims
7. 38Our products have in the past and may in the future be subject to recalls
8. 39We rely on third-party testing and analytical methods which are validated but have not yet been standardized
9. 40We may not be able to successfully develop new products or find a market for their sale
10. 41The Canadian excise duty framework may adversely affect our profitability
11. 42Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets, including changes in inflation, interest rates, trade policy and overall economic conditions

Risks Relating to Production and Distribution of Products

1. 43Our production facilities, and those of our strategic joint ventures, are integral to our operations, and any adverse changes or developments affecting such facilities may impact our business, financial condition and results of operations
2. 44We may experience breaches of security at our facilities, which may expose us to the loss of inventory and risks related to violations of applicable laws and regulations
3. 45Any actual or perceived failure by us to comply with laws, regulations or any other obligations relating to privacy, data protection or the protection or transfer of personal data, could adversely affect our business
4. 46Our cannabis cultivation operations are subject to risks inherent in an agricultural business
5. 47The inability of our suppliers to meet their financial or contractual obligations to us may result in disruption to our supply chain and could result in financial losses
6. 48We rely on third-party distributors and manufacturers to distribute and manufacture certain of our products, and those distributors and manufacturers may not perform their obligations

Risks Relating to Intellectual Property

1. 49We are subject to risks related to the protection and enforcement of our intellectual property rights, and we may be unable to protect or enforce our intellectual property rights
2. 50We may be unable to protect our inventions, trade secrets, and other intellectual property from discovery or unauthorized use
3. 51Our intellectual property rights may be invalid or unenforceable under applicable laws, and we may be unable to have issued or registered, and unable to enforce, our intellectual property rights
4. 52We may be subject to allegations that we are in violation of third-party intellectual property rights, and we may be found to infringe third-party intellectual property rights, possibly without the ability to obtain licenses necessary to use such third-party intellectual property rights
5. 53The technologies, processes and formulations we use may face competition or become obsolete

Risks Relating to Entry into New Markets

1. 54Entering into new jurisdictions is inherently risky, may not be successful and could be costly
2. 55Controlled substance and other legislation and treaties may restrict or limit our ability to research, manufacture and develop a commercial market for our products outside of the jurisdictions in which we currently operate, and our expansion into such jurisdictions is subject to risks
3. 56Investments and joint ventures outside of Canada are subject to the risks normally associated with any conduct of business in foreign countries, including varying degrees of political, legal, regulatory and economic risk

Risks Relating to Regulation and Compliance

1. 57We operate in highly regulated sectors where the regulatory environment is rapidly developing, and we may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where we carry on business
2. 58Our ability to grow, process, store and sell cannabis in Israel is dependent on maintaining our cannabis cultivation, production and distribution licenses and our ability to export products to, or import products from, Cronos Israel is also dependent on obtaining the relevant permits
3. 59Changes in the laws, regulations and guidelines governing cannabis may adversely impact our business
4. 60Our common shares are listed on the TSX and Nasdaq. We must comply with the TSX and Nasdaq requirements or guidelines when conducting business
5. 61We are constrained by law in our ability to market and advertise our products
6. 62Any rescheduling of U.S. Schedule I cannabis to Schedule III would have an uncertain impact on our business

Risks Relating to Competition

1. 63The markets in which we operate are increasingly competitive, and we may compete for market share with other companies, both domestically and internationally, that may have longer operating histories and more financial resources, manufacturing and marketing experience than us
2. 64We face competition from the illegal cannabis market
3. 65Regulatory non-compliance by licensed cannabis competitors may have an adverse effect on our business, results of operations and financial condition
4. 66We have been and may in the future be required to write down inventory due to downward pressure on market prices, which could have a material adverse effect on our results of operations or financial position
5. 67We may be unable to attract or retain employees with sufficient experience in the cannabis industry, and may prove unable to attract, develop and retain additional employees required for our development and future success

Risks Relating to the Altria Investment

1. 68Altria has significant influence over us following closing of the Altria Investment
2. 69We have discretion in the use of net proceeds from the Altria Investment and may not use them effectively
3. 70We may not realize the benefits of our strategic partnership with Altria, which could have an adverse effect on our business, financial condition and results of operations
4. 71Altria’s significant interest in us may impact the liquidity of our common shares
5. 72Future sales of our common shares by Altria could cause the market price for our common shares to fall
6. 73Conflicts of interest may arise between us and our directors and officers, including as a result of the continuing involvement of certain of our directors with Altria and its affiliates

Risks Relating to Our Common Shares

1. 74It is not anticipated that any dividend will be paid to holders of our common shares in the foreseeable future
2. 75The market price for our common shares has in the past been volatile and may continue to be volatile and subject to significant fluctuation
3. 76We may require additional capital in the future or be required to issue common shares pursuant to certain of our agreements, which may dilute holders of our securities
4. 77A substantial number of our securities are owned by a limited number of existing shareholders
5. 78Investors in the U.S. may have difficulty bringing actions and enforcing judgments against us and others based on securities law civil liability provisions
6. 79If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research about our business, our share price and trading volume could decline
7. 80We are dependent on our senior management
8. 81We may be unable to obtain insurance coverage at acceptable rates and there may be coverage limitations and other exclusions which may not be sufficient to cover our potential liabilities
9. 82Tax and accounting requirements may be interpreted or changed in ways that are complex and not necessarily anticipated by us, and we may face difficulty or be unable to implement and/or comply with any such interpretations or changes
10. 83Natural disasters, unusual weather, pandemic outbreaks, boycotts and geopolitical events or acts of terrorism could adversely affect our operations and financial results
11. 84Our business faces evolving and diverse expectations, requirements and demands from regulators, investors and other stakeholders, including with respect to environmental, social, governance and sustainability matters, which could expose us to numerous risks
12. 85Climate change may disrupt our business and our efforts to address concerns relating to climate change could result in damage to our reputation
13. 86Our financial performance is subject to risks of foreign exchange rate fluctuation, which could result in foreign exchange losses
14. 87Our business, financial condition, results of operations and cash flows could be adversely affected by disruptions in the global economy caused by the ongoing conflict between Russia and Ukraine